Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Bioscience Trends
|
April 21, 2022
Time to onset of drug-induced parkinsonism: Analysis using a large Japanese adverse event self-reporting database
Kenichiro Sato, Yoshiki Niimi, Tatsuo Mano, et al.
Biomedicines
|
August 29, 2024
Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease Treatment
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD
|
September 13, 2024
Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Study partner profile effects on CDR-SB change in anti-amyloid therapy evaluation
Ambre Mounié, Kenichiro Sato, Saki Nakashima, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 7, 2021
Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database
Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, et al.
Journal of Alzheimer'S Disease Reports
|
June 11, 2025
Audio review as a measure of quality assurance and control of cognitive assessments in Alzheimer's disease studies: An experience from Japanese Trial-Ready Cohort Study
Kenichiro Sato, Ryoko Ihara, Yoshiki Niimi, et al.
Journal of Alzheimer'S Disease : JAD
|
June 30, 2025
Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Bioscience Trends
|
July 15, 2021
The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database
Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, et al.
Frontiers in Dementia
|
July 31, 2024
<i>APOE</i>-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Fujita Medical Journal
|
February 3, 2022
Fatigue evaluated using the 16-item Parkinson Fatigue Scale (PFS-16) predicts Parkinson's disease prognosis
Yoshiki Niimi, Sayuri Shima, Yasuaki Mizutani, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Bioscience Trends
|
April 21, 2022
Time to onset of drug-induced parkinsonism: Analysis using a large Japanese adverse event self-reporting database
Kenichiro Sato, Yoshiki Niimi, Tatsuo Mano, et al.
Biomedicines
|
August 29, 2024
Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease Treatment
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD
|
September 13, 2024
Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2026
Study partner profile effects on CDR-SB change in anti-amyloid therapy evaluation
Ambre Mounié, Kenichiro Sato, Saki Nakashima, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
September 7, 2021
Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database
Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, et al.
Journal of Alzheimer'S Disease Reports
|
June 11, 2025
Audio review as a measure of quality assurance and control of cognitive assessments in Alzheimer's disease studies: An experience from Japanese Trial-Ready Cohort Study
Kenichiro Sato, Ryoko Ihara, Yoshiki Niimi, et al.
Journal of Alzheimer'S Disease : JAD
|
June 30, 2025
Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Bioscience Trends
|
July 15, 2021
The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database
Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, et al.
Frontiers in Dementia
|
July 31, 2024
<i>APOE</i>-ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Fujita Medical Journal
|
February 3, 2022
Fatigue evaluated using the 16-item Parkinson Fatigue Scale (PFS-16) predicts Parkinson's disease prognosis
Yoshiki Niimi, Sayuri Shima, Yasuaki Mizutani, et al.
Page
of 8